Individuals on this board have reported that Zhittya Genesis Medicine may be conducting an IPO soon. Is there any verity to this claim? With Zhittya also developing FGF-1 based drugs, how would that affect CVBT's IPO, if it ever happens?
What is CVBT's status on conducting an IPO? Is there a future for CVBT in open trading? How would the recent court case that has resulted in a $1 million dollar judgment against CVBT affect that IPO?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.